Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial(legacy) | 99 |
| Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial(legacy) | 93 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial | 0 | 6 | 0 | 5 | 0 | 5 | 4 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 71 |
| Australia | 62 |
| France | 8 |
| Netherlands | 8 |
| China | 6 |
| Germany | 5 |
| Vietnam | 5 |
| Sweden | 3 |
| Argentina | 1 |
| Finland | 1 |
Top City Views
| Views | |
|---|---|
| Kaleen | 39 |
| Ashburn | 24 |
| Rotterdam | 8 |
| Fairfield | 7 |
| Des Moines | 6 |
| Hanoi | 5 |
| Cambridge | 4 |
| New York | 4 |
| Boardman | 2 |
| Melbourne | 2 |